UroGen Pharma Ltd. (URGN) — Net Income

Annual figures by period end, from SEC filings.

2015-12-31: -$12.69M2016-12-31: -$1.94M2017-12-31: -$20.00M2018-12-31: -$75.66M2019-12-31: -$105.15M2020-12-31: -$128.48M2021-12-31: -$110.82M2022-12-31: -$109.78M2023-12-31: -$102.24M2024-12-31: -$126.87M2025-12-31: -$153.49M-$153.49M
2015-12-31Net Income (USD)2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$153.49M2026-03-02From 2025-01-01
2024-12-31-$126.87M2026-03-02From 2024-01-01
2023-12-31-$102.24M2025-03-10From 2023-01-01
2022-12-31-$109.78M2024-03-14From 2022-01-01
2021-12-31-$110.82M2023-03-24From 2021-01-01
2020-12-31-$128.48M2022-03-21From 2020-01-01
2019-12-31-$105.15M2021-03-18From 2019-01-01
2018-12-31-$75.66M2020-03-02From 2018-01-01
2017-12-31-$20.00M2020-03-02From 2017-01-01
2016-12-31-$1.94M2019-02-28From 2016-01-01
2015-12-31-$12.69M2018-03-15From 2015-01-01